CZ9896A3 - Peptide suppressing oxytocin activity - Google Patents

Peptide suppressing oxytocin activity Download PDF

Info

Publication number
CZ9896A3
CZ9896A3 CZ9698A CZ9896A CZ9896A3 CZ 9896 A3 CZ9896 A3 CZ 9896A3 CZ 9698 A CZ9698 A CZ 9698A CZ 9896 A CZ9896 A CZ 9896A CZ 9896 A3 CZ9896 A3 CZ 9896A3
Authority
CZ
Czechia
Prior art keywords
peptide
ile
composition
asn
acid residue
Prior art date
Application number
CZ9698A
Other languages
Czech (cs)
English (en)
Inventor
Carl-Johan Aurell
Per Melin
Anders Nilsson
Jerzy Trojnar
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of CZ9896A3 publication Critical patent/CZ9896A3/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/16Oxytocins; Vasopressins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CZ9698A 1993-07-13 1994-07-07 Peptide suppressing oxytocin activity CZ9896A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9302414A SE501678C2 (sv) 1993-07-13 1993-07-13 Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid

Publications (1)

Publication Number Publication Date
CZ9896A3 true CZ9896A3 (en) 1996-06-12

Family

ID=20390606

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ9698A CZ9896A3 (en) 1993-07-13 1994-07-07 Peptide suppressing oxytocin activity

Country Status (16)

Country Link
EP (1) EP0791012A1 (Direct)
JP (1) JPH09502427A (Direct)
KR (1) KR960702848A (Direct)
CN (1) CN1126999A (Direct)
AU (1) AU676071B2 (Direct)
CA (1) CA2163114A1 (Direct)
CZ (1) CZ9896A3 (Direct)
FI (1) FI960119L (Direct)
HU (1) HUT74874A (Direct)
IL (1) IL110267A0 (Direct)
NO (1) NO955059D0 (Direct)
PL (1) PL312568A1 (Direct)
SE (1) SE501678C2 (Direct)
TW (1) TW268009B (Direct)
WO (1) WO1995002609A1 (Direct)
ZA (1) ZA945090B (Direct)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9604341D0 (sv) * 1996-11-26 1996-11-26 Ferring Bv Hepta-peptide oxytocin analogue
AU2003211011A1 (en) 2002-02-27 2003-09-09 Ferring Bv Intermediates and methods for making heptapeptide oxytocin analogues
CA3001057A1 (en) * 2015-10-06 2017-04-13 Ferring B.V. New methods for making barusiban and its intermediates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5373089A (en) * 1988-09-02 1994-12-13 Northwestern University Oxytocin antagonist
SE9002384D0 (sv) * 1990-07-09 1990-07-09 Ferring Ab Derivat av baklobshormoner
SE501677C2 (sv) * 1993-06-18 1995-04-10 Ferring Bv Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel

Also Published As

Publication number Publication date
SE501678C2 (sv) 1995-04-10
CA2163114A1 (en) 1995-01-26
NO955059L (no) 1995-12-13
AU676071B2 (en) 1997-02-27
WO1995002609A1 (en) 1995-01-26
TW268009B (Direct) 1996-01-11
SE9302414L (sv) 1995-01-14
EP0791012A1 (en) 1997-08-27
KR960702848A (ko) 1996-05-23
IL110267A0 (en) 1994-10-21
NO955059D0 (no) 1995-12-13
AU7240694A (en) 1995-02-13
PL312568A1 (en) 1996-04-29
FI960119A0 (fi) 1996-01-10
ZA945090B (en) 1995-02-22
FI960119A7 (fi) 1996-01-10
HUT74874A (en) 1997-02-28
SE9302414D0 (sv) 1993-07-13
HU9503768D0 (en) 1996-02-28
FI960119L (fi) 1996-01-10
JPH09502427A (ja) 1997-03-11
CN1126999A (zh) 1996-07-17

Similar Documents

Publication Publication Date Title
US6143722A (en) Heptapeptide oxytocin analogues
AU2010244857A1 (en) High penetration prodrug compositions of peptides and peptide-related compounds
SE501677C2 (sv) Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel
TWI364291B (en) Peptidic vasopressin receptor agonists
CZ9896A3 (en) Peptide suppressing oxytocin activity
IE59556B1 (en) Therapeutic somatostatin analogs
CA2405704C (en) Bombesin analogs for treatment of cancer
KR0171614B1 (ko) 혈관활성 바소토신 유도체
EP1198478B1 (en) Somatostatin analogs and their use for the treatment of cancer
CA2405724C (en) Substance p analogs for the treatment of cancer
IE912378A1 (en) Derivatives of pituitary posterior lobe hormones
CZ993A3 (en) derivatives of neurohypophysis lobe hormones